
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 23, 2024, titled "Press release on Q3 FY24 and 9M FY24 Results".
Filed with NSE ·

Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 23, 2024, titled "Press release on Q3 FY24 and 9M FY24 Results".
6ix hasn’t read this filing yet.
Alivus Life Sciences Ltd on 6ix
Follow Alivus Life Sciences into a list and get an email when it puts out news.
Follow Alivus Life Sciences